Vaxart, Inc.
VXRT· OTC
VXRTVaxart, Inc.
Filed Mar 14, 2024 · 10-K · 74 days after period end · 0001437749-24-007865
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021 | Q4 2020 |
|---|---|---|---|---|
| Revenue | $3.25M | $22.00K | $74.00K | $356.00K |
| Net Income | -$17.38M | -$23.92M | -$20.76M | -$13.86M |
| EPS Diluted | — | — | -$0.17 | -$0.13 |
Vaxart, Inc. · CIK 72444 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2023 · filed Mar 14, 2024 · 74 d after period end
